Drug-Induced Sudden Death & Ventricular Arrhythmia
NCT00102180 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 31000000
Last updated 2020-12-21
Summary
To investigate the relationship between the use of prescription drugs and the occurrence of ventricular arrhythmia and sudden death.
Conditions
- Cardiovascular Diseases
- Death, Sudden, Cardiac
- Heart Diseases
- Ventricular Arrhythmia
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
collaborator NIH - lead OTHER
Principal Investigators
-
Sean Hennessy, PharmD, PhD · University of Pennsylvania
Eligibility
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2005-01-31
- Primary Completion
- 2008-11-30
- Completion
- 2008-11-30
More Related Trials
-
Effects of Intravenous K201 on the Restoration of Sinus Rhythm in Subjects With Symptomatic Atrial Fibrillation
NCT01259622 ·Status: TERMINATED ·Phase: PHASE2
-
Comparing the Effects of Amiodarone, Sotalol, and Placebo in Maintaining Sinus Rhythm in Patients With Atrial Fibrillation Converted to Sinus Rhythm
NCT00007605 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of APL180
NCT00907998 ·Status: COMPLETED ·Phase: PHASE1
-
Direct Oral Anticoagulants Pharmacodynamics in Octogenarian Patients With Atrial Fibrillation
NCT02623049 ·Status: UNKNOWN
-
Investigate the Effect of AZD1305 on Patients With Left Ventricular Dysfunction
NCT00748982 ·Status: COMPLETED ·Phase: PHASE2
-
Role of Amino Acids and Genetic Disorder in Pathogenesis of Heart Failure
NCT03590522 ·Status: UNKNOWN
-
INhalation of Flecainide to Convert Recent Onset SympTomatic Atrial Fibrillation to siNus rhyThm (INSTANT)
NCT03539302 ·Status: COMPLETED ·Phase: PHASE2
-
Monitoring Drug-induced Myocarditis (CardiTOX)
NCT03855982 ·Status: COMPLETED
-
SGLT2i As Anti Arrhythmic Therapy to Prevent Sudden Cardiac Deaths.
NCT03366181 ·Status: COMPLETED
-
Safety and Hemodynamic Effects and Pharmacokinetics of CXL-1020 in Patients With Stable Heart Failure
NCT01092325 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluating the Risk of Serious Ventricular Arrhythmia and Sudden Cardiac Death Among Users of Domperidone
NCT00925457 ·Status: COMPLETED
-
Effectiveness of Oral Anticoagulants in Elderly Patients With Non-Valvular Atrial Fibrillation and Heart Failure
NCT03508271 ·Status: COMPLETED
-
Adherence to Oral Anticoagulants in Patients With Atrial Fibrillation
NCT05469308 ·Status: UNKNOWN ·Phase: NA
-
A Study of the Pharmacokinetic and Pharmacodynamic Responses in Healthy and Altered Human Cardiovascular Systems
NCT03098680 ·Status: TERMINATED ·Phase: PHASE1
-
Safety and Efficacy Study of an A1-Adenosine Receptor Agonist to Slow Heart Rate in Atrial Fibrillation
NCT00040001 ·Status: COMPLETED ·Phase: PHASE2
-
Intravenous Allopurinol to Improve Heart Function in Individuals With Dilated Cardiomyopathy
NCT00281255 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Study of K201 Injection on Restoration of Sinus Rhythm in Subjects Who Are in Atrial Fibrillation
NCT00626652 ·Status: COMPLETED ·Phase: PHASE2
-
An Exploratory Safety and Efficacy Clinical Study of CARDIX-101 for the Treatment of Chronic Bradycardia
NCT05117346 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Amiodarone and N-Acetylcysteine or Amiodarone Alone for Preventing Atrial Fibrillation After Thoracic Surgery
NCT02750319 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Hemodynamic Effects of Rolofylline in the Treatment of Patients With Heart Failure (7418-503)
NCT00729222 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of APL180 in Healthy Volunteers and Patients With Coronary Heart Disease (CHD)
NCT00568594 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Dronedarone in Pacemakers Patients With Paroxysmal Atrial Fibrillation
NCT01070667 ·Status: UNKNOWN ·Phase: PHASE4
-
This Study Observes the Use of New Oral Anticoagulants (NOACs) in Patients With a Heart Rhythm Disorder in Spain
NCT03285373 ·Status: COMPLETED
-
Covid-19 Vaccine Associated Myocarditis and Pericarditis in Norway
NCT05610423 ·Status: ENROLLING_BY_INVITATION
-
Flecainide Acetate Inhalation Solution for Cardioversion of Recent-Onset, Symptomatic Atrial Fibrillation
NCT05039359 ·Status: TERMINATED ·Phase: PHASE3